Authors
Latest:
How Does the EUA for the COVID-19 Vaccines Work?FDA approvals of vaccines usually take 10 to 15 years, but the pandemic necessitates emergency action.
Latest:
Supporting Medication Adherence With Motivational InterviewingMotivational Interviewing is a collaborative conversation style that can empower patients to stay the course and achieve better outcomes.
Latest:
Pharmacy Schools Can Break Down Barriers Between Pharmacists, Deaf CommunityMost pharmacists and technicians are unaware of resources that aid in communication.
Latest:
Oncology Pharmacists Bring Value and Contribute to Cancer CareOncology pharmacists are as diverse as the cancers they manage and have key roles in the following areas of the cancer care continuum.
Latest:
From Setbacks to Solutions: Pioneering Safe RSV Vaccines for Infants, ChildrenWith respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity
Latest:
The Challenges in Launching Alaska's First Pharmacy SchoolA shortage of pharmacists led to a call for pharmacy education in Alaska that echoed across the state.
Latest:
Review of 3 Alternative Pathways to Access Non–FDA-Approved DrugsNon–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Latest:
Avoiding Weight-Loss Pitfalls: How Organizations Can Strengthen Their Medication StrategyWhen used correctly, weight-loss medications, such as glucagon-like peptide-1 (GLP-1) medications, can be a tool to help reduce costs and provide clinical results.
Latest:
SGLT2 Inhibitors Are Underutilized for Inpatient Heart Failure TreatmentCardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.
Latest:
The Perfect Ingredient: Vaccine Education With Pharmacy Community Health WorkersIn Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.
Latest:
Regional Trends Reinforcing Breast Cancer Therapeutics MarketOver the next few years, undiagnosed breast cancer cases may add to the demand for more rigorous end-stage treatments and therapeutics.
Latest:
How the White House's New FDA Commissioner Caused the Baby Formula CrisisThe FDA's current way of inspecting facilities for quality control is badly outdated and is politically unworkable, unreliable, and unsafe.
Latest:
As Easy as ABE: A Pharmacist’s Overview of Updates to the COPD GOLD GuidelinesData show that dose-response relationships and long-term safety of ICS in people with chronic obstructive pulmonary disease are unclear and require further investigation.
Latest:
Assessing the Impact of Patient Assistance Programs on Financial Toxicity in Oral OncologyPAPs can significantly reduce OOP costs for patients.
Latest:
The Ethics and Economics of California’s End of Life Option ActIn addition to moral arguments, economic issues must be considered.
Latest:
Implementing CDC’s Core Elements of SepsisThe agency outlines key elements for building effective hospital sepsis programs.
Latest:
Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia TreatmentBRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.
Latest:
Current Drug Pathways in Non–Small Cell Lung CancerAdvancements in genomic and mutational analysis show that up to 60% of adenocarcinomas and up to 50% to 80% of squamous cell carcinomas (SCC) have a known oncogenic driver mutation.
Latest:
Five Fast Facts About IVIGBy functioning as an antibody replacement therapy, IVIG can be used to manage a wide range of inflammatory and autoimmune disorders.
Latest:
How 2023 Can Be the Year of Clinical PharmacogenomicsIn terms of science and technology, the health care community has everything needed to clinically implement pharmacogenomics testing.
Latest:
Dengue Vaccine: What Pharmacists Need to KnowThe FDA approved the first vaccine for dengue disease in May 2019.
Latest:
Offering Specialty Infusions May Be Worth the Work for Oncology PracticesExpanding operations to provide specialty infusions can provide benefits to both patients and oncology practices.
Latest:
Driving Patient Safety With New Pharmacy HIT StandardsNew standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.
Latest:
Multiple Myeloma Therapy Often Causes Cardiovascular ComplicationsMany patients have baseline risk factors present at diagnosis because of older age and disease-related elements.
Latest:
Pirtobrutinib and BTK Inhibitors in the CLL Treatment LandscapeThis review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Latest:
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing SarcomaThis retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.
Latest:
Recognize the Value of Health Care VolunteersThe health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
